Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-710
Closed -$108K 2221
2020
Q4
$108K Hold
710
﹤0.01% 1869
2020
Q3
$131K Buy
710
+620
+689% +$102K ﹤0.01% 1775
2020
Q2
$10K Buy
+90
New +$9.16K ﹤0.01% 2096
2015
Q4
Sell
-5
Closed -$7K 1935
2015
Q3
$7K Hold
5
﹤0.01% 1855
2015
Q2
$37K Hold
5
﹤0.01% 1787
2015
Q1
$45K Hold
5
﹤0.01% 1699
2014
Q4
$45K Hold
5
﹤0.01% 1631
2014
Q3
$37K Buy
+5
New +$47.2K ﹤0.01% 1680

Other funds holding IMUX

STRS Ohio's IMUX Position: Q1 2021 in Review

STRS Ohio sold out of Immunic (IMUX) in Q1 2021, closing a stake of 710 shares — an estimated $108K sold.

STRS Ohio first reported a position in IMUX in Q3 2014 and held it in 8 quarters. The position peaked at $131K in Q3 2020. 63 funds tracked by Wall St. Rank hold IMUX as of Q1 2021.

  • STRS Ohio reported no remaining Immunic position as of Q1 2021 after selling out during the quarter.
  • STRS Ohio sold 710 Immunic shares in Q1 2021, an estimated $108K.
  • STRS Ohio first reported a position in Immunic in Q3 2014 and held it in 8 quarters.
  • STRS Ohio's Immunic position peaked at $131K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Immunic as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.